Bionano Genomics/$BNGO
1D1W1M3M6MYTD1Y5YMAX
Capital at risk
About Bionano Genomics
Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes. Geographically, it operates in the Americas, EMEA, and Asia Pacific, of which the EMEA region generates the majority of its revenue. It generates product revenue from sales of its OGM and Ionic Purification systems and consumables, which include its instruments and their VIA software.
- Ticker
- $BNGO
- Sector
- Health
- Primary listing
- NASDAQ
- Employees
- 96
- Headquarters
- San Diego, United States
- Website
- bionano.com
Bionano Genomics Metrics
BasicAdvanced
$13M
-
-$2.69
-
-
Price and volume
Market cap
$13M
52-week high
$2.23
52-week low
$1.00
Average daily volume
226K
Financial strength
Current ratio
2.073
Quick ratio
1.139
Long term debt to equity
0.201
Total debt to equity
0.232
Interest coverage (TTM)
-101.30%
Profitability
EBITDA (TTM)
-20.752
Gross margin (TTM)
47.98%
Net profit margin (TTM)
-96.87%
Operating margin (TTM)
-97.11%
Effective tax rate (TTM)
-0.20%
Revenue per employee (TTM)
$320,000
Management effectiveness
Return on assets (TTM)
-30.10%
Return on equity (TTM)
-77.20%
Valuation
Price to revenue (TTM)
0.396
Price to book
0.53
Price to tangible book (TTM)
0.53
Price to free cash flow (TTM)
-0.646
Free cash flow yield (TTM)
-154.85%
Free cash flow per share (TTM)
-1.703
Growth
Revenue change (TTM)
8.23%
Earnings per share change (TTM)
-77.10%
3-year revenue growth (CAGR)
-2.57%
3-year earnings per share growth (CAGR)
-81.59%
What the Analysts think about Bionano Genomics
Analyst ratings (Buy, Hold, Sell) for Bionano Genomics stock.
Analyst projections of the future price of Bionano Genomics stock.
Bionano Genomics Financial Performance
Revenues and expenses
Bionano Genomics Earnings Performance
Company profitability
Upcoming events
No upcoming events
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.